Follow!24 Aug 2020 09:54
Holding(s) in Company
Southampton, UK,: Synairgen plc (LSE: SNG), the respiratory drug discovery and development company, announces that it was informed on 21 August 2020 that Leonard Licht, a private investor, now holds 7,375,000 ordinary shares of 1 pence each in the capital of the Company, representing 4.93% of the Company's issued share capital.
There is a clear reason for this.